Product photograph of the current pack. Each physical unit carries the same blue-teal ZX label artwork, a batch code and a scratch-off verification panel.
Selective Estrogen Receptor Modulators
Nolvadex
Tamoxifen Citrate
- Compound
- Tamoxifen Citrate
- Brand
- Nolvadex
- Manufacturer
- Zyvex Pharmaceuticals
- Presentation
- 100 tabs
- Strength
- 20 mg/tab
- Route
- Oral
- Storage
- 15–25 °C, protected from light, do not freeze
Batch analysis
Independent batch results for Nolvadex are not yet published. They will be added here once testing is complete.
Product information
About Nolvadex
20 mg per tablet · 100 tablets · Zyvex Pharmaceuticals
Nolvadex from Zyvex Pharmaceuticals contains tamoxifen citrate at 20 mg per tablet and comes in a pack of 100 tablets.
This prospect summarises composition, clinical considerations and handling. It supports professional review and does not replace an individual prescription or verified instructions for the exact preparation.
Basic Identification & Composition
Product Name & Active Ingredient
Nolvadex is the product name used by Zyvex Pharmaceuticals. The ingredient discussed in the following sections is tamoxifen citrate, classified as a selective oestrogen receptor modulator.
Qualitative & Quantitative Composition
| Property | Details |
|---|---|
| Product name | Nolvadex |
| Manufacturer | Zyvex Pharmaceuticals |
| Active ingredient | Tamoxifen Citrate |
| Strength | 20 mg per tablet |
| Package | 100 tablets |
| Drug class | Selective oestrogen receptor modulator |
| Chemical formula | C32H37NO8 |
| Dosage form and route | Tablet; oral |
Dosage Form
A solid tablet for oral administration. Each tablet provides a measured amount of active ingredient. Confirm suitability with a pharmacist before splitting or crushing; appearance and score lines alone do not establish accurate dose division.
Clinical Particulars
Nolvadex uses
Nolvadex from Zyvex Pharmaceuticals contains tamoxifen citrate. Tamoxifen is used to treat oestrogen-sensitive breast cancer and, in selected patients, reduce breast-cancer risk. A common medical reference is 20 mg orally daily; the duration depends on the treatment setting. Doses are normally expressed as tamoxifen equivalent, which must be distinguished from citrate-salt mass.
People using anabolic steroids take tamoxifen to address breast tenderness or enlargement and as part of post-cycle attempts to restore hormonal function. Blocking breast oestrogen receptors does not necessarily lower circulating oestrogen.
A forum analysis reported a mean tamoxifen dose of 22 mg daily and a median duration of 22 days for receptor modulators collectively. These figures describe reported behaviour rather than an established recovery schedule. Blood-clot risk remains relevant at therapeutic doses.
Dosage and Administration
Tamoxifen is taken orally according to a specialist prescription. Medicinal labels commonly express tablet strength as tamoxifen equivalent even when the ingredient is tamoxifen citrate. For Nolvadex 20 mg, the pharmacist should confirm that strength convention before calculating a dose. Do not assume that 20 mg of the citrate salt and 20 mg of tamoxifen base are interchangeable.
Contraindications
Avoid use with known hypersensitivity. In the risk-reduction setting, a history of deep-vein thrombosis or pulmonary embolism, or concurrent coumarin anticoagulation, is a contraindication. Treatment in other settings requires an individual specialist assessment.
Warnings and Precautions
Important risks include venous thrombosis, pulmonary embolism, stroke and uterine malignancy. Report unexplained vaginal bleeding, unilateral leg swelling, chest pain or sudden neurological symptoms. Eye and liver problems also require review.
Risks and Interactions
Drug & Food Interactions
Warfarin can interact significantly. Strong CYP2D6 inhibitors, including paroxetine and fluoxetine, may reduce formation of an active metabolite. Do not stop an antidepressant abruptly; the prescriber should review alternatives.
Pregnancy and Lactation
Avoid pregnancy and breastfeeding during treatment. A clinician should advise nonhormonal contraception and the appropriate interval after treatment ends.
Side Effects and Adverse Reactions
Hot flushes, vaginal discharge, menstrual changes, nausea and fluid retention are reported. Blood clots, stroke, uterine disease and visual changes are less frequent but potentially serious.
Overdose Protocol
For a suspected overdose, contact a poison-information service or urgent medical care and provide the product, amount, time and other substances taken. Collapse, seizures or breathing difficulty require emergency help. Do not induce vomiting or attempt an antidote at home. Clinical treatment depends on symptoms and the substances involved.
Scientific & Technical Data
Pharmacodynamics
Tamoxifen modulates oestrogen receptors. It blocks oestrogen signalling in some tissues while exerting partial oestrogen-like effects in others, explaining its differing effects on breast, bone and endometrium.
Pharmacokinetics
Tamoxifen is absorbed orally and extensively metabolised, including through CYP2D6 and CYP3A pathways. Active metabolites contribute to its effects. Tamoxifen's terminal half-life is about five to seven days, with some metabolites persisting longer.
Storage and Handling
Tamoxifen tablets are generally stored at room temperature, protected from light and moisture. Keep tablets in their original, tightly closed container, protected from excess heat and moisture and out of the sight and reach of children. Follow the temperature limits and expiry date on the pack. Return expired or unwanted medicines through a pharmacy or medicine take-back programme; do not flush them.
Browse more